3Gillissen A, Nowak D. Characterization of N-acetylcysteine and ambroxol in anti-oxidant therapy [J], Respir Med, 1998,92:6092.
4Tersmoto S, Suzuki M, Ohga E,et al. Effects of ambroxol on spontaneous or stimulated generation of reaotive oxygen species by bronchoalveolar lavage cells harvested from patients with or without chronic obstructive pulmonary diseases [ J ]. Pharmacology,1999,59 : 135-141.
5Pfeifer S,Zissel G, Kienast K, et al. Reduction of cytokine release of blood and bronchoalveolar mononuclear cells by ambroxol [ J ].Eur J Med Res, 1997,2:129-132.
6Pairet M, Engelmann P, Yon Nicolai H, et al, Ambroxol improves the broncho-spasmolytic activity of clenbuterol in the guinea pig[J]. J Pharm Pharmacol, 1997,49 : 184-186.
7W Couet, J Girault. Steady-state bioavailability and pharmacokinetics of ambroxol and clenbuterol administered alone and combined in a new oral formulation[J]. Intern J Clin Pharmacol,Therapy Toxicol, Vol. 27 No. 9-1989 (467-472).
8Michel P, Peter E. Ambroxol improves the broncho-spasmolytic activity of clenbuterol in the guinea-pig[ J]. J Pharm Pharmacol,1997,49,184-186.
9.新药(西药)临床研究指导原则汇编[M].中华人民共和国卫生部药政局,.51.
10Pitcairn GR, New man SP. Tissue attenuation corrections in gamma scintigraphy [J]. J Aerosol Med, 1997, 10(1) : 187-198.
